杰瑟普隆萨俱乐部举办首届隆萨竞赛 - fox56.com
Jessup Lonza Club serves up first Lonza competition - fox56.com
#Jessup Lonza#Lonza Club#Lonza competition#Club serves#Lonza
生命科学资讯
生物技术与制药领域的最新动态
2001届毕业生杰森·伯恩特加入龙沙集团，担任集团运营新主管兼执行副总裁——西点军校校友会报道
Jason Berndt ’01 Joins Lonza as New Head of Group Operations, Executive VP - West Point Association of Graduates
#Group Operations#Joins Lonza#Point Association#West Point#Jason Berndt
龙沙集团(VTX:LONN)上周3.4%的跌幅令持股50%的个人投资者和机构双双受创——雅虎财经报道
Lonza Group AG's (VTX:LONN) 3.4% loss last week hit both individual investors who own 50% as well as institutions - Yahoo Finance
#Yahoo Finance#Lonza Group#week hit#individual investors#Finance Lonza
龙沙集团任命Jason Berndt为集团运营负责人 - 合同制药
Lonza Appoints Jason Berndt as Head of Group Operations - Contract Pharma
#Appoints Jason#Jason Berndt#Group Operations#Contract Pharma#Lonza Appoints
2025年十大合同开发与生产组织 - 基因工程与生物技术新闻
Top 10 Contract Development and Manufacturing Organizations 2025 - GEN - Genetic Engineering and Biotechnology News
#Contract Development#Manufacturing Organizations#Genetic Engineering#GEN#Contract
龙沙集团UC-II胶原蛋白获NutraStrong认证，临床证据支持其对膝关节灵活性的益处——营养展望
Lonza’s UC-II Collagen earns NutraStrong certification, backed by clinical evidence on knee flexibility - Nutritional Outlook
#Nutritional Outlook#UC-II Collagen#Collagen earns#NutraStrong certification#earns NutraStrong
Lonza CHI获得NutraStrong胶原蛋白认证——营养视野网报道
Lonza CHI receives NutraStrong Collagen Verified certification - nutritioninsight.com
#Collagen Verified#Lonza CHI#CHI receives#NutraStrong Collagen#Verified certification
龙沙集团高管人事变动 - 医药通讯
Executive changes at Lonza - The Pharma Letter
#Pharma Letter#Letter Executive#Pharma#Lonza#Letter
SGS Nutrasource授予Lonza胶囊与健康成分NutraStrong胶原蛋白认证——营养保健品行业评论
SGS Nutrasource awards NutraStrong Collagen Verified certification to Lonza Capsules & Health Ingredients - Nutraceutical Business Review
#Lonza Capsules#Health Ingredients#Collagen Verified#SGS Nutrasource#Nutraceutical Business
ToolGen在荷兰对Lonza提起专利侵权诉讼 - PR Newswire
ToolGen Files Patent Infringement Lawsuit Against Lonza in the Netherlands - PR Newswire
#Files Patent#Patent Infringement#Infringement Lawsuit#ToolGen Files#Newswire ToolGen
确保营养保健品经久不衰：龙沙CHI谈生物利用度与感官吸引力 - 营养洞察网
Future-proofing nutraceuticals: Lonza CHI on bioavailability and sensory appeal - nutritioninsight.com
#Lonza CHI#Future-proofing nutraceuticals#sensory appeal#Lonza#CHI
求解溶解度：复杂分子的药物配方——《自然》
Solving for solubility: Drug formulation for complex molecules - Nature
#Drug formulation#complex molecules#Nature Solving#molecules Nature#Drug
龙沙集团将重点展示防腐与消毒解决方案——非织造布行业
Lonza to Highlight Preservation and Disinfection Solutions - Nonwovens Industry -
#Nonwovens Industry#Highlight Preservation#Disinfection Solutions#Solutions Nonwovens#Industry
朗萨·斯托弗讣告（2025年）- 佛罗里达州圣彼得堡 - 坦帕湾时报 - 传承 | 讣告
Lonza Stover Obituary (2025) - St. Petersburg, Florida - Tampa Bay Times - Legacy | Obituary
#Tampa Bay#Bay Times#Stover Obituary#Lonza Stover#Times Legacy
Excellos、Lonza与Akadeum生命科学联手通过提升起始材料质量推进细胞疗法制造进程 - PR新闻通讯社
Excellos, Lonza, and Akadeum Life Sciences Unite to Advance Cell Therapy Manufacturing Through Enhanced Starting Material Quality - PR Newswire
#Akadeum Life#Life Sciences#Sciences Unite#Advance Cell#Cell Therapy
三强联手：龙沙、Excellos与Akadeum共促细胞与基因治疗领域革新——BioProcess International报道
Three amigos: Lonza, Excellos, and Akadeum team to improve CGT landscape - BioProcess International
#Akadeum team#improve CGT#CGT landscape#BioProcess International#Lonza
临床前陷阱：如何避免代价高昂的配方失败——《自然》杂志
Preclinical pitfalls: How to avoid costly formulation failures - Nature
#Preclinical pitfalls#avoid costly#costly formulation#formulation failures#Nature Preclinical
龙沙集团2025年上半年财报：营收超预期，每股收益符合预估——雅虎财经
Lonza Group First Half 2025 Earnings: Revenues Beat Expectations, EPS In Line - Yahoo Finance
#Revenues Beat#Beat Expectations#Yahoo Finance#Lonza Group#Line Yahoo
隆萨财报亮点：瓦卡维尔工厂表现突出——《瓦卡维尔记者报》
Vacaville facility a standout in Lonza earnings report - The Vacaville Reporter
#Vacaville Reporter#Lonza earnings#Vacaville facility#Reporter Vacaville#earnings report
龙沙集团在新战略下业绩回升，上调盈利预期——医药通讯
Lonza lifts forecast as performance rebounds under new strategy - The Pharma Letter
#Pharma Letter#Lonza lifts#lifts forecast#performance rebounds#Letter Lonza